We are now looking for a highly motivated Postdoctoral Researcher in the Drug Metabolism and Pharmacokinetics (DMPK) section of our Nonclinical Development department (2 years).
The purpose of Idorsia is to discover, develop, and commercialize innovative medicines to help more patients. Headquartered in Switzerland - a biotech-hub of Europe - Idorsia is a high-potential biopharmaceutical company, specialized in the discovery, development and commercialization of innovative small molecules, with the aim of transforming the horizon of therapeutic options.